Revision history of "Modulating the immune system with oncolytic adenovirus as a strategy for diffuse stem tumors (DIPGs)" (Q3202585)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 11:1411:14, 8 October 2024DG Regio talk contribs 79,733 bytes 0 Changed label, description and/or aliases in pt
  • curprev 11:1411:14, 8 October 2024DG Regio talk contribs 79,733 bytes +13 Set a claim value: summary (P836): O glioma de haste difusa (DIPG) é o tumor cerebral pediátrico mais letal. A sobrevivência média destas crianças é inferior a um ano. Isso ressalta a necessidade de novos tratamentos. Delta-24-RGD é um vírus oncolítico tumoral selectivo que já foi testado em vários ensaios clínicos de fase I em doentes com BBM recorrente (um no nosso centro; CUN). Os resultados preliminares destes ensaios revelaram que a injeção intratumoral do vírus instiga uma fase...

22 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 14:1314:13, 4 August 2022DG Regio talk contribs 78,447 bytes +54,237 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

5 December 2021

13 October 2021

  • curprev 00:4100:41, 13 October 2021DG Regio talk contribs 12,883 bytes +160 Changed label, description and/or aliases in en: translated_label
  • curprev 00:4100:41, 13 October 2021DG Regio talk contribs 12,723 bytes +2,488 Created claim: summary (P836): Diffuse stem glioma (DIPG) is the most lethal pediatric brain tumor. The average survival of these children is less than one year. This highlights the need for new treatments. Delta-24-RGD is a selective tumor oncolytic virus that has already been tested in several phase I clinical trials in patients with recurrent BBM (one in our center; CUN). Preliminary results from these trials revealed that intratumoral injection of the virus instigates an...

11 October 2021

10 October 2021

8 October 2021